Buy Ghrp-2 Peptid

Direct Summary: Sourcing GHRP-2 for Laboratory Research

To buy GHRP-2 peptid (Growth Hormone-Releasing Peptide-2) for specialized laboratory protocols, investigators require high-purity, fully characterized synthetic material free from biological contaminants. GHRP-2 is a synthetic hexapeptide classified as a selective ghrelin receptor agonist and potent growth hormone secretagogue used exclusively in scientific research to investigate pituitary signaling dynamics, somatotroph recruitment, and neuroendocrine pathways.

PX1 Research manufactures GHRP-2 in the USA within GMP-compliant environments, supplying institutional research laboratories with analytical-grade lyophilizate. Each batch includes comprehensive documentation, including lot-specific Certificates of Analysis (COA) detailing purity verified via RP-HPLC and identity confirmed through electrospray ionization mass spectrometry (ESI-MS). Browse our complete catalog of research peptides or view the dedicated GHRP-2 product page for specification data.

Molecular Structure and Secretagogue Pharmacodynamic Profile

GHRP-2 (also designated as Pralmorelin) is a synthetic hexapeptide with the chemical sequence D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2 and a molecular weight of approximately 717.9 g/mol. As an artificial ligand of the growth hormone secretagogue receptor (GHS-R1a), GHRP-2 exhibits high binding affinity for the ghrelin receptor family located predominantly on anterior pituitary somatotrophs and hypothalamic neurons.

Unlike native Growth Hormone-Releasing Hormone (GHRH), which activates the GHRH receptor via intracellular cyclic adenosine monophosphate (cAMP) accumulation, GHRP-2 acts through the GHS-R1a pathway. Receptor activation triggers a phospholipase C (PLC) cascade, leading to intracellular inositol trisphosphate (IP3) generation and subsequent mobilization of intracellular calcium stores. Preclinical studies indicate that this distinct mechanism produces a synergistic growth hormone release when co-administered alongside endogenous or synthetic GHRH analogs.

Investigators interested in the foundational pathways of pituitary signaling can explore our comprehensive analysis of growth hormone secretagogues overview within the PX1 research library.

Preclinical Research Findings: Somatotroph Activation and Endocrine Dynamics

In vitro and animal models have consistently demonstrated the capacity of GHRP-2 to induce dose-dependent growth hormone (GH) secretion from anterior pituitary tissue culture. In rodent models, peripheral or central administration of GHRP-2 triggers acute GH pulses characterized by rapid onset and short terminal elimination half-lives. This robust activation makes GHRP-2 a benchmark compound in secretagogue bioassays.

Beyond isolated GH release, preclinical investigations show that GHRP-2 weak-to-moderate activation of downstream secondary endocrine axes leads to minor blips in cortisol and prolactin secretion in specific animal models. This multi-receptor crosstalk provides critical insight into the selectivity thresholds of GHS-R1a agonists compared to non-peptidic small molecules. Researchers examining these cellular mechanisms often analyze the full scope of GHRP-2 mechanism of action in controlled laboratory environments.

Comparative Secretagogue Analysis: GHRP-2, GHRP-6, and Ipamorelin

When designing comparative secretagogue protocols, researchers frequently evaluate GHRP-2 alongside related compounds in the hexapeptide and pentapeptide families. Understanding the unique binding kinetics, potency profiles, and receptor selectivities across these molecules is essential for experimental design.

GHRP-2 demonstrates significantly higher potency in driving GH release than its structural predecessor, GHRP-6, while displaying a slightly lower orexigenic (appetite-stimulating) effect in rodent behavioral studies. Conversely, selective secretagogues like Ipamorelin offer targeted GHS-R1a activation without elevating secondary hormones like cortisol or prolactin. For protocols focusing on GHRH-receptor co-stimulation rather than GHS-R1a pathways, researchers frequently utilize peptide analogs such as Sermorelin to evaluate dual-pathway convergence.

Ghrelin Receptor Binding and Orexigenic Receptor Signaling

Because GHRP-2 serves as a synthetic ghrelin mimetic, it interacts directly with central and peripheral GHS-R1a receptors involved in energy homeostasis and metabolic regulation. In vivo rodent experiments demonstrate that central infusion of GHRP-2 stimulates short-term food intake, though to a lesser magnitude than GHRP-6 or native acyl-ghrelin.

This differential orexigenic response allows scientists to isolate GH secretagogue actions from feeding behavior pathways. In vitro binding studies reveal that subtle amino acid substitutions in the hexapeptide backbone alter binding kinetics at hypothalamic NPY/AgRP neuron terminals, providing a valuable molecular probe for mapping central nervous system control over metabolic rate and nutrient partitioning.

Quality Verification: Analytical HPLC, Mass Spectrometry, and Endotoxin Standards

When purchasing GHRP-2 for scientific study, empirical verification of purity and chemical identity is vital to eliminate experimental variables. PX1 Research enforces strict quality assurance standards, submitting every lot to independent ISO 17025-accredited laboratories for unbiased testing.

Analytical validation for PX1 Research compounds includes:

1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Ensures chemical purity exceeds 98%, confirming the absence of truncated sequences or synthesis side-products.

2. Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies exact molecular weight and structural identity against theoretical reference values.

3. Endotoxin Testing (LAL Assay): Measures bacterial endotoxin levels to ensure values remain well below strict research limits (<0.01 EU/mg), preventing inflammatory confounders in cell culture assays.

4. Mass Spectrometry Traceability: Lot-specific COAs are made accessible directly to institutional clients to maintain complete chain-of-custody data.

Laboratory Reconstitution and Chemical Stability Protocols

Synthetic GHRP-2 is supplied as a lyophilized (freeze-dried) sterile powder in vacuum-sealed glass vials to ensure long-term stability during transport and storage. Proper handling techniques must be observed to maintain peptide integrity prior to in vitro application.

Reconstitution should be performed under aseptic laboratory conditions using sterile diluents such as 0.9% Bacteriostatic Sodium Chloride or Sterile Bacteriostatic Water, depending on protocol requirements. The solvent should be directed gently along the glass vial wall rather than sprayed directly onto the lyophilized cake. Gentle swirl agitation—never violent shaking—is recommended to fully dissolve the material without causing mechanical shear stress or aggregation of the peptide chains.

Unreconstituted lyophilized vials should be stored at -20°C for long-term preservation, protected from direct light exposure. Once reconstituted into liquid solution, aliquots should be maintained at 2°C to 8°C for short-term experimentation or ultra-low temperatures (-80°C) to prevent hydrolysis and enzymatic degradation over extended timelines.

Procurement and Institutional Lab Ordering

PX1 Research simplifies the acquisition of analytical-grade research compounds for academic institutions, biotechnology entities, and independent laboratory operations. All products ship directly from our state-of-the-art facilities in California and Arizona, guaranteeing rapid turnaround times and optimized supply chain efficiency.

Orders placed Monday through Friday before 12:00 PM PST qualify for same-day dispatch. For high-throughput screening projects, long-term animal studies, or custom assay development requiring significant volume, laboratories can access volume pricing through our wholesale research portal.